公开(公告)号：US20110173708A1

公开(公告)日：2011-07-14

申请号：US13031009

申请日：2011-02-18

申请人： Katherin E. Combs ,  Ling Ling Culbertson ,  Juan Delmas-Mata ,  Frederic de Sauvage ,  Liangfen Fan ,  Gretchen Frantz ,  Leslie Jane Green ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Franklin Peale ,  Heidi Phillips ,  Michelle Rohrer ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Ching-Yun Wang ,  Wen Xiong ,  Peter Vogel

发明人： Katherin E. Combs ,  Ling Ling Culbertson ,  Juan Delmas-Mata ,  Frederic de Sauvage ,  Liangfen Fan ,  Gretchen Frantz ,  Leslie Jane Green ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Franklin Peale ,  Heidi Phillips ,  Michelle Rohrer ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Ching-Yun Wang ,  Wen Xiong ,  Peter Vogel

IPC分类号： G01N33/00

CPC分类号： C12N15/8509 ,  A01K2217/075 ,  A01K2267/0306 ,  A01K2267/0362 ,  A01K2267/0375

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地，本发明提供转基因小鼠，其包括在PRO226，​​PRO257，PRO268，PRO290，PRO36006，PRO363，PRO365，PRO382，PRO444，PRO705，PRO1071，PRO1125，PRO1134，PRO1155，PRO1281，PRO1343，PRO1379，PRO1380，PRO1387，PRO1419中的中断 ，PRO1433，PRO1474，PRO1550，PRO1571，PRO1572，PRO1759，PRO1904，PRO35193，PRO4341，PRO4348，PRO4369，PRO4381，PRO4407，PRO4425，PRO4985，PRO4989，PRO5737，PRO5800，PRO5993，PRO6017，PRO7174，PRO9744，PRO9821，PRO9852，PRO9873 ，PRO10196，PRO34778，PRO20233，PRO21956，PRO57290，PRO38465，PRO38683或PRO85161基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20120272341A1

公开(公告)日：2012-10-25

申请号：US13473322

申请日：2012-05-16

申请人： Katherin E. Combs ,  Ling Ling Culbertson ,  Juan Delmas-Mata ,  Frederic de Sauvage ,  Liangfen Fan ,  Gretchen Frantz ,  Leslie Jane Green ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Franklin Peale ,  Heidi Phillips ,  Michelle Rohrer ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Ching-Yun Wang ,  Wen Xiong ,  Peter Vogel

发明人： Katherin E. Combs ,  Ling Ling Culbertson ,  Juan Delmas-Mata ,  Frederic de Sauvage ,  Liangfen Fan ,  Gretchen Frantz ,  Leslie Jane Green ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Franklin Peale ,  Heidi Phillips ,  Michelle Rohrer ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Ching-Yun Wang ,  Wen Xiong ,  Peter Vogel

IPC分类号： G01N33/50 ,  C12Q1/02 ,  G01N33/92 ,  G01N33/483

CPC分类号： C12N15/8509 ,  A01K2217/075 ,  A01K2267/0306 ,  A01K2267/0362 ,  A01K2267/0375

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地，本发明提供转基因小鼠，其包括在PRO226，​​PRO257，PRO268，PRO290，PRO36006，PRO363，PRO365，PRO382，PRO444，PRO705，PRO1071，PRO1125，PRO1134，PRO1155，PRO1281，PRO1343，PRO1379，PRO1380，PRO1387，PRO1419中的中断 ，PRO1433，PRO1474，PRO1550，PRO1571，PRO1572，PRO1759，PRO1904，PRO35193，PRO4341，PRO4348，PRO4369，PRO4381，PRO4407，PRO4425，PRO4985，PRO4989，PRO5737，PRO5800，PRO5993，PRO6017，PRO7174，PRO9744，PRO9821，PRO9852，PRO9873 ，PRO10196，PRO34778，PRO20233，PRO21956，PRO57290，PRO38465，PRO38683或PRO85161基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20080124344A1

公开(公告)日：2008-05-29

申请号：US11814549

申请日：2006-07-18

申请人： Katherin E. Combs ,  Ling Ling Culbertson ,  Juan Delmas-Mata ,  Frederic de Sauvage ,  Liangfen Fan ,  Gretchen Frantz ,  Leslie Jane Green ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Franklin Peale ,  Heidi Phillips ,  Michelle Rohrer ,  Tracy E.W. Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Ching-Yun Wang ,  Wen Xiong ,  Peter Vogel

发明人： Katherin E. Combs ,  Ling Ling Culbertson ,  Juan Delmas-Mata ,  Frederic de Sauvage ,  Liangfen Fan ,  Gretchen Frantz ,  Leslie Jane Green ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Franklin Peale ,  Heidi Phillips ,  Michelle Rohrer ,  Tracy E.W. Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Ching-Yun Wang ,  Wen Xiong ,  Peter Vogel

IPC分类号： A61K39/395 ,  A01K67/00 ,  A61P43/00

CPC分类号： C12N15/8509 ,  A01K2217/075 ,  A01K2267/0306 ,  A01K2267/0362 ,  A01K2267/0375

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地，本发明提供转基因小鼠，其包括在PRO226，​​PRO257，PRO268，PRO290，PRO36006，PRO363，PRO365，PRO382，PRO444，PRO705，PRO1071，PRO1125，PRO1134，PRO1155，PRO1281，PRO1343，PRO1379，PRO1380，PRO1387，PRO1419中的中断 ，PRO1433，PRO1474，PRO1550，PRO1571，PRO1572，PRO1759，PRO1904，PRO35193，PRO4341，PRO4348，PRO4369，PRO4381，PRO4407，PRO4425，PRO4985，PRO4989，PRO5737，PRO5800，PRO5993，PRO6017，PRO7174，PRO9744，PRO9821，PRO9852，PRO9873 ，PRO10196，PRO34778，PRO20233，PRO21956，PRO57290，PRO38465，PRO38683或PRO85161基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20120005766A1

公开(公告)日：2012-01-05

申请号：US13205917

申请日：2011-08-09

申请人： Kristi Rae Bollinger ,  Katherin E. Combs ,  Jaime-Jo Cunningham ,  Ling Ling Culbertson ,  Frederic J. de Sauvage ,  Joel Edwards ,  Leslie Jane Green ,  Rosemary Girgis ,  Allison Anne Byers Horner ,  Dina Rebecca McLain ,  Charles Montgomery ,  Laurie Jeanette Minze ,  Bobby Joe Payne ,  Heidi Phillips ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Teresa Gail Townsend ,  Peter Vogel

发明人： Kristi Rae Bollinger ,  Katherin E. Combs ,  Jaime-Jo Cunningham ,  Ling Ling Culbertson ,  Frederic J. de Sauvage ,  Joel Edwards ,  Leslie Jane Green ,  Rosemary Girgis ,  Allison Anne Byers Horner ,  Dina Rebecca McLain ,  Charles Montgomery ,  Laurie Jeanette Minze ,  Bobby Joe Payne ,  Heidi Phillips ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Teresa Gail Townsend ,  Peter Vogel

IPC分类号： A61K49/00 ,  C12Q1/68 ,  C40B30/04 ,  C12Q1/02

CPC分类号： A01K67/0276 ,  A01K2217/075 ,  A01K2227/105 ,  A01K2267/03 ,  C12N15/8509

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO188, PRO235, PRO266, PRO337, PRO361, PRO539, PRO698, PRO717, PRO846, PRO874, PRO98346, PRO1082, PRO1097, PRO1192, PRO1268, PRO1278, PRO1303, PRO1308, PRO1338, PRO1378, PRO1415, PRO1867, PRO1890, PRO3438, PRO19835, PRO36915, PRO36029, PRO4999, PRO5778, PRO5997, PRO6079, PRO6090, PRO7178, PRO21184, PRO7434, PRO9822, PRO9833, PRO9836, PRO9854, PRO9862, PRO10284, PRO37510, PRO35444, PRO20473, PRO21054 or PRO35246 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; cyc abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地，本发明提供转基因小鼠，其包括在PRO188，PRO235，PRO266，PRO337，PRO361，PRO539，PRO698，PRO717，PRO846，PRO874，PRO98346，PRO1082，PRO1097，PRO1192，PRO1268，PRO1278，PRO1303，PRO1308，PRO1338，PRO1378中的中断 ，PRO1415，PRO1867，PRO1890，PRO3438，PRO19835，PRO36915，PRO36029，PRO4999，PRO5778，PRO5997，PRO6079，PRO6090，PRO7178，PRO21184，PRO7434，PRO9822，PRO9833，PRO9836，PRO9854，PRO9862，PRO10284，PRO37510，PRO35444，PRO20473，PRO21054 或PRO35246基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 循环异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20120030776A1

公开(公告)日：2012-02-02

申请号：US12910746

申请日：2010-10-22

申请人： Katherin E. Combs ,  Ling Ling Culbertson ,  Frederic de Sauvage ,  Zhiyong Ding ,  Joel Edwards ,  Rosemary Girgis ,  Allison Anne Byers Horner ,  Harald Junge ,  Jagath Reddy Junutula ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Heidi Phillips ,  Ni Nancy Qian ,  Carolina Rangel ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Peter Vogel ,  Weilan Ye

发明人： Katherin E. Combs ,  Ling Ling Culbertson ,  Frederic de Sauvage ,  Zhiyong Ding ,  Joel Edwards ,  Rosemary Girgis ,  Allison Anne Byers Horner ,  Harald Junge ,  Jagath Reddy Junutula ,  Erin Marie Massey ,  Dina Rebecca McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Heidi Phillips ,  Ni Nancy Qian ,  Carolina Rangel ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Peter Vogel ,  Weilan Ye

IPC分类号： A61K49/00 ,  C12Q1/48 ,  C12Q1/42 ,  C40B30/04 ,  C12Q1/02

CPC分类号： A01K67/0276 ,  A01K2217/075 ,  A01K2227/105 ,  A01K2267/03 ,  C12N15/8509

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地，本发明提供转基因小鼠，其包括PRO69122，PRO204，PRO214，PRO222，PRO234，PRO265，PRO309，PRO332，PRO342，PRO356，PRO540，PRO618，PRO944，PRO994，PRO1079，PRO1110，PRO1122，PRO1138，PRO1190，PRO1272中的中断 ，PRO1286，PRO1295，PRO1309，PRO1316，PRO1383，PRO1384，PRO1431，PRO1434，PRO1475，PRO1481，PRO1568，PRO1573，PRO1599，PRO1604，PRO1605，PRO1693，PRO1753，PRO1755，PRO1777，PRO1788，PRO1864，PRO1925，PRO1926，PRO3566，PRO4330 ，PRO4423，PRO36935，PRO4977，PRO4979，PRO4980，PRO4981，PRO5801，PRO5995，PRO6001，PRO6095，PRO6182，PRO7170，PRO7171，PRO7436，PRO9912，PRO9917，PRO37337，PRO37496，PRO19646，PRO21718，PRO19820，PRO21201，PRO20026，PRO20110，PRO23203 或PRO35250基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20110182883A1

公开(公告)日：2011-07-28

申请号：US13040049

申请日：2011-03-03

申请人： Katherin E. Combs ,  Frederic de Sauvage ,  Liangfen Fan ,  Ellen Filvaroff ,  Allison Anne Byers Horner ,  Bryan Irving ,  Jagath Reddy Junutula ,  Erin Marie Massey ,  Dina Rebecca Mclain ,  Laurie Jeanette Minze ,  Charles Montgomery ,  Bobby Joe Payne ,  Heidi Phillips ,  Carolina Rangel ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Teresa Gail Townsend ,  Peter Vogel

发明人： Katherin E. Combs ,  Frederic de Sauvage ,  Liangfen Fan ,  Ellen Filvaroff ,  Allison Anne Byers Horner ,  Bryan Irving ,  Jagath Reddy Junutula ,  Erin Marie Massey ,  Dina Rebecca Mclain ,  Laurie Jeanette Minze ,  Charles Montgomery ,  Bobby Joe Payne ,  Heidi Phillips ,  Carolina Rangel ,  Tracy Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Teresa Gail Townsend ,  Peter Vogel

IPC分类号： A61K39/395 ,  A61P3/00 ,  A61P9/00 ,  A61P25/00 ,  A61P19/00 ,  G01N33/00

CPC分类号： C12Q1/6883 ,  A01K67/0276 ,  A01K2217/075 ,  A01K2227/105 ,  A01K2267/03 ,  A61K49/0008 ,  C12N15/8509 ,  C12Q2600/158

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO218, PRO228, PRO271, PRO273, PRO295, PRO302, PRO305, PRO326, PRO386, PRO655, PRO162, PRO788, PRO792, PRO940, PRO941, PRO1004, PRO1012, PRO1016, PRO474, PRO5238, PRO1069, PRO1111, PRO1113, PRO1130, PRO1195, PRO1271, PRO1865, PRO1879, PRO3446, PRO3543, PRO4329, PRO4352, PRO5733, PRO9859, PRO9864, PRO9904, PRO9907, PRO10013, PRO90948, PRO28694, PRO16089, PRO19563, PRO19675, PRO20084, PRO21434, PRO50332, PRO38465 or PRO346 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地说，本发明提供了包含PRO218，PRO228，PRO271，PRO273，PRO295，PRO302，PRO305，PRO326，PRO386，PRO655，PRO162，PRO788，PRO792，PRO940，PRO941，PRO1004，PRO1012，PRO1016，PRO474，PRO5238中的中断的转基因小鼠 ，PRO1069，PRO1111，PRO1113，PRO1130，PRO1195，PRO1271，PRO1865，PRO1879，PRO3446，PRO3543，PRO4329，PRO4352，PRO5733，PRO9859，PRO9864，PRO9904，PRO9907，PRO10013，PRO90948，PRO28694，PRO16089，PRO19563，PRO19675，PRO20084，PRO21434 ，PRO50332，PRO38465或PRO346基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20080311107A1

公开(公告)日：2008-12-18

申请号：US11814136

申请日：2007-02-09

申请人： Kristi Rae Bollinger ,  Katherin E. Combs ,  Jaime-Jo Cunningham ,  Ling Ling Culbertson ,  Frederic J. de Sauvage ,  Joel A. Edwards ,  Leslie Jane Green ,  Rosemary Girgis ,  Allison Anne Byers Horner ,  Dina Rebecca McLain ,  Charles Montgomery ,  Laurie Jeanette Minze ,  Bobby Joe Payne ,  Heidi Phillips ,  Trac Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Teresa Gail Townsend ,  Peter Vogel

发明人： Kristi Rae Bollinger ,  Katherin E. Combs ,  Jaime-Jo Cunningham ,  Ling Ling Culbertson ,  Frederic J. de Sauvage ,  Joel A. Edwards ,  Leslie Jane Green ,  Rosemary Girgis ,  Allison Anne Byers Horner ,  Dina Rebecca McLain ,  Charles Montgomery ,  Laurie Jeanette Minze ,  Bobby Joe Payne ,  Heidi Phillips ,  Trac Ellen Willis Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Tracy Tzu-Ling Tang ,  Teresa Gail Townsend ,  Peter Vogel

IPC分类号： A61K39/395 ,  A61K51/00 ,  C12N5/06 ,  A61P25/00 ,  A61P27/12 ,  C07K16/00

CPC分类号： A01K67/0276 ,  A01K2217/075 ,  A01K2227/105 ,  A01K2267/03 ,  C12N15/8509

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO188, PRO235, PRO266, PRO337, PRO361, PRO539, PRO698, PRO717, PRO846, PRO874, PRO98346, PRO1082, PRO1097, PRO1192, PRO1268, PRO1278, PRO1303, PRO1308, PRO1338, PRO1378, PRO1415, PRO1867, PRO1890, PRO3438, PRO19835, PRO36915, PRO36029, PRO4999, PRO5778, PRO5997, PRO6079, PRO6090, PRO7178, PRO21184, PRO7434, PRO9822, PRO9833, PRO9836, PRO9854, PRO9862, PRO10284, PRO37510, PRO35444, PRO20473, PRO21054 or PRO35246 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地，本发明提供转基因小鼠，其包括在PRO188，PRO235，PRO266，PRO337，PRO361，PRO539，PRO698，PRO717，PRO846，PRO874，PRO98346，PRO1082，PRO1097，PRO1192，PRO1268，PRO1278，PRO1303，PRO1308，PRO1338，PRO1378中的中断 ，PRO1415，PRO1867，PRO1890，PRO3438，PRO19835，PRO36915，PRO36029，PRO4999，PRO5778，PRO5997，PRO6079，PRO6090，PRO7178，PRO21184，PRO7434，PRO9822，PRO9833，PRO9836，PRO9854，PRO9862，PRO10284，PRO37510，PRO35444，PRO20473，PRO21054 或PRO35246基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20090313707A1

公开(公告)日：2009-12-17

申请号：US11814361

申请日：2006-05-18

申请人： Katherin E. Combs ,  Ling Ling Culbertson ,  Frederic J. de Sauvage ,  Zhiyong Ding ,  Joel Edwards ,  Rosemary Girgis ,  Allison A. B. Horner ,  Harald Junge ,  Jagath Reddy Junutula ,  Erin Marie Massey ,  Dina R. McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Heidi Phillips ,  Ni Nancy Qian ,  Carolina Rangel ,  Tracy E. W. Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Peter Vogel ,  Weilan Ye

发明人： Katherin E. Combs ,  Ling Ling Culbertson ,  Frederic J. de Sauvage ,  Zhiyong Ding ,  Joel Edwards ,  Rosemary Girgis ,  Allison A. B. Horner ,  Harald Junge ,  Jagath Reddy Junutula ,  Erin Marie Massey ,  Dina R. McLain ,  Charles Montgomery ,  Bobby Joe Payne ,  Heidi Phillips ,  Ni Nancy Qian ,  Carolina Rangel ,  Tracy E. W. Sevaux ,  Zheng-Zheng Shi ,  Mary Jean Sparks ,  Joy Anne Stala ,  Peter Vogel ,  Weilan Ye

IPC分类号： G01N33/00 ,  C12N5/06 ,  C12Q1/02

CPC分类号： A01K67/0276 ,  A01K2217/075 ,  A01K2227/105 ,  A01K2267/03 ,  C12N15/8509

摘要： The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

摘要翻译： 本发明涉及转基因动物，以及与基因功能表征相关的组合物和方法。 具体地，本发明提供转基因小鼠，其包括PRO69122，PRO204，PRO214，PRO222，PRO234，PRO265，PRO309，PRO332，PRO342，PRO356，PRO540，PRO618，PRO944，PRO994，PRO1079，PRO1110，PRO1122，PRO1138，PRO1190，PRO1272中的中断 ，PRO1286，PRO1295，PRO1309，PRO1316，PRO1383，PRO1384，PRO1431，PRO1434，PRO1475，PRO1481，PRO1568，PRO1573，PRO1599，PRO1604，PRO1605，PRO1693，PRO1753，PRO1755，PRO1777，PRO1788，PRO1864，PRO1925，PRO1926，PRO3566，PRO4330。 ，PRO4423，PRO36935，PRO4977，PRO4979，PRO4980，PRO4981，PRO5801，PRO5995，PRO6001，PRO6095，PRO6182，PRO7170，PRO7171，PRO7436，PRO9912，PRO9917，PRO37337，PRO37496，PRO19646，PRO21718，PRO19820，PRO21201，PRO20026，PRO20110，PRO23203 或PRO35250基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防，改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管，内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。

公开(公告)号：US20060216289A1

公开(公告)日：2006-09-28

申请号：US11448387

申请日：2006-06-06

申请人： Frederic de Sauvage ,  Robert Klein ,  Heidi Phillips ,  Arnon Rosenthal

发明人： Frederic de Sauvage ,  Robert Klein ,  Heidi Phillips ,  Arnon Rosenthal

IPC分类号： G01N33/53 ,  C07H21/04 ,  C12P21/06 ,  A61K39/395 ,  C07K14/71 ,  C07K16/28

CPC分类号： C07K16/2863 ,  C07K14/71 ,  C07K2317/75 ,  C07K2319/00 ,  C12Q1/485 ,  G01N33/573 ,  G01N33/74 ,  G01N2500/04 ,  G01N2500/10

摘要： The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing, and immunoadhesions and antibodies to mammalian GFRα3, a novel α-subunit receptor of the GDNF (i.e. GFR) receptor family. It further relates to an assay for measuring activation of an α-subunit receptor by detecting tyrosine kinase receptor activation (i.e., autophosphorylation) or other activities related to ligand-induced α-subunit receptor homo-dimerization or homo-oligomerization.

摘要翻译： 本发明涉及核苷酸序列，包括表达序列标签（EST），寡核苷酸探针，多肽，载体和宿主细胞，其表达和免疫粘附和抗体对哺乳动物GFRalpha3，GDNF（即GFR）受体家族的新型α-亚单位受体 。 它进一步涉及通过检测酪氨酸激酶受体激活（即自身磷酸化）或与配体诱导的α-亚基受体均二聚化或同型寡聚化相关的其他活性来测量α-亚单位受体活化的测定法。

公开(公告)号：US20070232535A1

公开(公告)日：2007-10-04

申请号：US11529680

申请日：2006-09-27

申请人： Frederic de Sauvage ,  Robert Klein ,  Heidi Phillips ,  Arnon Rosenthal

发明人： Frederic de Sauvage ,  Robert Klein ,  Heidi Phillips ,  Arnon Rosenthal

IPC分类号： A61K39/00 ,  C07K14/00 ,  G01N33/53

CPC分类号： C07K16/2863 ,  C07K14/71 ,  C07K2317/75 ,  C07K2319/00 ,  C12Q1/485 ,  G01N33/573 ,  G01N33/74 ,  G01N2500/04 ,  G01N2500/10

摘要： The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing, and immunoadhesions and antibodies to mammalian GFRα3, a novel α-subunit receptor of the GDNF (i.e. GFR) receptor family. It further relates to an assay for measuring activation of an α-subunit receptor by detecting tyrosine kinase receptor activation (i.e., autophosphorylation) or other activities related to ligand-induced subunit receptor homo-dimerization or homo-oligomerization.

摘要翻译： 本发明涉及核苷酸序列，包括表达序列标签（EST），寡核苷酸探针，多肽，载体和宿主细胞，其表达和免疫粘附和抗体对哺乳动物GFRalpha3，GDNF（即GFR）受体家族的新型α-亚单位受体 。 它进一步涉及通过检测酪氨酸激酶受体活化（即自身磷酸化）或与配体诱导的亚单位受体均二聚化或同型寡聚化相关的其它活性来测量α亚基受体活化的测定法。